Literature DB >> 8502776

Chlamydia-induced reactive arthritis.

L H Silveira1, F Gutiérrez, E Scopelitis, M L Cuéllar, G Citera, L R Espinoza.   

Abstract

Chlamydia trachomatis infection is now recognized as the most prevalent veneral disease in the Western World. The majority of cases of Reiter's syndrome, one type of reactive arthritis, are secondary to sexually transmitted infections. Evidence of urogenital C. trachomatis infection is found in 36% to 61% of cases of Reiter's syndrome. We investigated the prevalence of infection by this organism in a group of patients with spondyloarthropathies. Positive cultures were obtained in 39.4% of patients with Reiter's syndrome, as well as in 22.2% of patients with psoriatic arthritis and in 20% of patients with ankylosing spondylitis. An important percentage of patients also had positive serum antibodies against C. trachomatis (62.1% of patients with Reiter's syndrome), suggesting presence of infection at some point during the course of the disease. Our findings and those from other authors support the use of long-term antibiotic therapy in patients with reactive arthritis, mainly in those in whom positive culture for C. trachomatis has been obtained as well as in their sex partners.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8502776

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  8 in total

Review 1.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 2.  Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review.

Authors:  Telma Thrastardottir; Thorvardur Jon Love
Journal:  Rheumatol Int       Date:  2017-11-09       Impact factor: 2.631

3.  Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial.

Authors:  N Putschky; H-G Pott; J G Kuipers; H Zeidler; M Hammer; J Wollenhaupt
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

4.  Optimized testing for C. trachomatis DNA in synovial fluid samples in clinical practice.

Authors:  J Freise; I Bernau; S Meier; H Zeidler; J G Kuipers
Journal:  Z Rheumatol       Date:  2015-11       Impact factor: 1.372

Review 5.  Undifferentiated spondyloarthritis: recent clinical and therapeutic advances.

Authors:  Vanesa Cruzat; Raquel Cuchacovich; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

6.  Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis.

Authors:  John D Carter; Hervé C Gérard; Luis R Espinoza; Louis R Ricca; Joanne Valeriano; Jessica Snelgrove; Cynthia Oszust; Frank B Vasey; Alan P Hudson
Journal:  Arthritis Rheum       Date:  2009-05

Review 7.  Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

8.  [History of reactive arthritis. Historical milestones and future].

Authors:  H Zeidler
Journal:  Z Rheumatol       Date:  2022-08-25       Impact factor: 1.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.